Cancer
YF-N01-002
A Phase I/II Clinical Study Evaluating the Safety, Tolerability, and Efficacy of N-3C01 as Monotherapy and in Combination with PD-(L)1 Monoclonal Antibody in Patients with Advanced Malignant Solid Tumors.
Trial overview
Clinical Area
Medical Oncology
Disease
Basket
Disease site
Basket
Study Phase
I
Trial Identifiers
Registration number: NCT07639450
Principal Investigator(s)
··
··